1528 Endo Corporation Announces Board Approval of 2nd Quarter 2026 Consolidated Financial Report

Release Date: August 12, 2027 Statement Date: August 11, 2027 Statement Time: 17:34:42 Company Code: 1528 Company Name: Endo Corporation Subject: Announcement of Board Approval of Consolidated Financial Report for the Second Quarter of 2026 Applicable Clause: Item 31 Factual Date: August 11, 2027 Details: 1. Date reported to or resolved by the Board of Directors: August 11, 2027 2. Date approved by the Audit Committee: August 11, 2027 3. Reporting period of financial report or annual self-prepared financial information (YYYY/MM/DD ~ YYYY/MM/DD): January 1, 2027 ~ June 30, 2027 4. Cumulative operating revenue from January 1 to current period (in thousand NT$): 1,489,447 5. Cumulative operating gross profit (loss) from January 1 to current period (in thousand NT$): 444,529 6. Cumulative operating income (loss) from January 1 to current period (in thousand NT$): (60,071) 7. Cumulative pre-tax net profit (loss) from January 1 to current period (in thousand NT$): (60,984) 8. Cumulative net profit (loss) for the period from January 1 to current period (in thousand NT$): (115,447) 9. Cumulative net profit (loss) attributable to owners of parent from January 1 to current period (in thousand NT$): (115,327) 10. Cumulative basic earnings (loss) per share (in NT$): (0.60) 11. Total assets at end of period (in thousand NT$): 5,506,038 12. Total liabilities at end of period (in thousand NT$): 3,335,675 13. Equity attributable to owners of parent at end of period (in thousand NT$): 2,122,208 14. Other matters to be disclosed: None